Provided by Tiger Fintech (Singapore) Pte. Ltd.

Abeona Therapeutics

5.89
-0.1100-1.83%
Post-market: 5.890.00000.00%19:30 EDT
Volume:1.21M
Turnover:7.11M
Market Cap:301.31M
PE:-6.22
High:6.13
Open:6.03
Low:5.77
Close:6.00
Loading ...
May 20, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 17, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Major Issues Report

8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 11, 2023

Major Issues Report

8-K - Current report
Apr 10, 2023

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 29, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 29, 2023

Major Issues Report

8-K - Current report
Mar 22, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 13, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 06, 2022

Correspondence

CORRESP [Cover] - Correspondence
Nov 16, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 14, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]